Advertisement

Complications Post-TAVI

  • Chekrallah Chamandi
  • Josep Rodés-Cabau
Chapter

Abstract

Transcatheter aortic valve replacement (TAVR) has become the standard of care for inoperable patients with symptomatic severe aortic stenosis [1] and a good alternative to surgical aortic valve replacement for patients at high surgical risk [2]. Worldwide, two types of transcatheter heart valves (THVs) have been most used to date: the balloon-expandable Edwards valve (Cribier-Edwards, Edwards SAPIEN, SAPIEN XT, and SAPIEN 3; Edwards Lifesciences, Irvine, CA) and the self-expandable CoreValve system (CoreValve, Evolut, Evolut R; Medtronic, Minneapolis, MN). In the past few years, other transcatheter valves have also received CE mark approval and are now commonly used (e.g., Direct Flow, Lotus Valve, Portico, JenaValve, Symetis). Despite significant progress in the technology of transcatheter valves over the last decade, several complications remain associated with this less-invasive procedure. This chapter seeks to review the major significant complications following TAVR. Methods of prevention and treatment of those hurdles will also be appraised.

References

  1. 1.
    Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607.PubMedCrossRefGoogle Scholar
  2. 2.
    Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98.PubMedCrossRefGoogle Scholar
  3. 3.
    Makkar RR, Fontana GP, Jilaihawi H, et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012;366:1696–704.PubMedCrossRefGoogle Scholar
  4. 4.
    Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686–95.PubMedCrossRefGoogle Scholar
  5. 5.
    Thomas M, Schymik G, Walther T, et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2011;124:425–33.PubMedCrossRefGoogle Scholar
  6. 6.
    Gilard M, Eltchaninoff H, Iung B, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012;366:1705–15.PubMedCrossRefGoogle Scholar
  7. 7.
    Rodes-Cabau J, Webb JG, Cheung A, et al. Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience. J Am Coll Cardiol. 2012;60:1864–75.PubMedCrossRefGoogle Scholar
  8. 8.
    Hamm CW, Mollmann H, Holzhey D, et al. The German Aortic Valve Registry (GARY): in-hospital outcome. Eur Heart J. 2014;35:1588–98.PubMedCrossRefGoogle Scholar
  9. 9.
    Moat NE, Ludman P, de Belder MA, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the UK TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol. 2011;58:2130–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Chieffo A, Buchanan GL, Van Mieghem NM, et al. Transcatheter aortic valve implantation with the Edwards SAPIEN versus the Medtronic CoreValve Revalving system devices: a multicenter collaborative study: the PRAGMATIC Plus Initiative (Pooled-RotterdAm-Milano-Toulouse In Collaboration). J Am Coll Cardiol. 2013;61:830–6.PubMedCrossRefGoogle Scholar
  11. 11.
    Di Mario C, Eltchaninoff H, Moat N, et al. The 2011–12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4571 patients. EuroIntervention. 2013;8:1362–71.PubMedCrossRefGoogle Scholar
  12. 12.
    Mack MJ, Brennan JM, Brindis R, et al. Outcomes following transcatheter aortic valve replacement in the United States. JAMA. 2013;310:2069–77.PubMedCrossRefGoogle Scholar
  13. 13.
    Linke A, Wenaweser P, Gerckens U, et al. Treatment of aortic stenosis with a self-expanding transcatheter valve: the International Multi-centre ADVANCE Study. Eur Heart J. 2014;35(38):2672–84. doi: 10.1093/eurheartj/ehu162.PubMedCrossRefGoogle Scholar
  14. 14.
    Abdel-Wahab M, Mehilli J, Frerker C, et al. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA. 2014;311:1503–14.PubMedCrossRefGoogle Scholar
  15. 15.
    Takagi H, Umemoto T, for the ALICE (All-Literature Investigation of Cardiovascular Evidence) Group. Impact of paravalvular aortic regurgitation after transcatheter aortic valve implantation on survival. Int J Cardiol. 2016;221:46–51.PubMedCrossRefGoogle Scholar
  16. 16.
    Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research consortium-2 consensus document. J Am Coll Cardiol. 2012;60:1438–54.PubMedCrossRefGoogle Scholar
  17. 17.
    Lerakis S, Hayek SS, Douglas PS. Paravalvular aortic leak after transcatheter aortic valve replacement: current knowledge. Circulation. 2013;127:397–407.PubMedCrossRefGoogle Scholar
  18. 18.
    Athappan G, Patvardhan E, Tuzcu EM, et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol. 2013;61(15):1585–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Nombela-Franco L, Ruel M, Radhakrishnan S, et al. Comparison of hemodynamic performance of self-expandable CoreValve versus balloon-expandable Edwards SAPIEN aortic valves inserted by catheter for aortic stenosis. Am J Cardiol. 2013;111(7):1026–33.PubMedCrossRefGoogle Scholar
  20. 20.
    Popma J, Adams D, Reardon M, et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol. 2014;63:1972–81.PubMedCrossRefGoogle Scholar
  21. 21.
    Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370:1790–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Reardon MJ, Adams DH, Kleiman NS, et al. 2-Year outcomes in patients undergoing surgical or self-expanding transcatheter aortic valve replacement. J Am Coll Cardiol. 2015;66:113–21.PubMedCrossRefGoogle Scholar
  23. 23.
    Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation. 2011;123:299–308.PubMedCrossRefGoogle Scholar
  24. 24.
    van Belle E, Juthier F, Susen S, et al. Postprocedural aortic regurgitation in balloon-expandable and self-expandable transcatheter aortic valve replacement procedures: analysis of predictors and impact on long-term mortality: insights from the FRANCE2 Registry. Circulation. 2014;129:1415–27.PubMedCrossRefGoogle Scholar
  25. 25.
    Miyazaki S, Agricola E, Panoulas VF, et al. Influence of baseline ejection fraction on the prognostic value of paravalvular leak after transcatheter aortic valve implantation. Int J Cardiol. 2015;190:277–81.PubMedCrossRefGoogle Scholar
  26. 26.
    Mack MJ, Leon MB, Smith CR, et al. 5-Year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;1:8.Google Scholar
  27. 27.
    Jerez-Valero M, Urena M, Webb JG, et al. Clinical impact of aortic regurgitation after transcatheter aortic valve replacement: insights into the degree and acuteness of presentation. JACC Cardiovasc Interv. 2014;7:1022–32.PubMedCrossRefGoogle Scholar
  28. 28.
    Koos R, Mahnken AH, Dohmen G, et al. Association of aortic valve calcification severity with the degree of aortic regurgitation after transcatheter aortic valve implantation. Int J Cardiol. 2011;150:142–5.PubMedCrossRefGoogle Scholar
  29. 29.
    Colli A, D’Amico R, Kempfert J, et al. Transesophageal echocardiographic scoring for transcatheter aortic valve implantation: impact of aortic cusp calcification on postoperative aortic regurgitation. J Thorac Cardiovasc Surg. 2011;142:1229–35.PubMedCrossRefGoogle Scholar
  30. 30.
    Yared K, Garcia-Camarero T, Fernandez-Friera L, et al. Impact of aortic regurgitation after transcatheter aortic valve implantation: results from the REVIVAL trial. JACC Cardiovasc Imaging. 2012;5:469–77.PubMedCrossRefGoogle Scholar
  31. 31.
    Détaint D, Lepage L, Himbert D, et al. Determinants of significant paravalvular regurgitation after transcatheter aortic valve: implantation impact of device and annulus discongruence. JACC Cardiovasc Interv. 2009;2:821–7.PubMedCrossRefGoogle Scholar
  32. 32.
    Schultz CJ, Tzikas A, Moelker A, et al. Correlates on MSCT of paravalvular aortic regurgitation after transcatheter aortic valve implantation using the Medtronic CoreValve prosthesis. Catheter Cardiovasc Interv. 2011;78:446–55.PubMedCrossRefGoogle Scholar
  33. 33.
    Généreux P, Head SJ, Hahn R, et al. Paravalvular leak after transcatheter aorticvalve replacement: the new Achilles’ heel? A comprehensive review of the literature. J Am Coll Cardiol. 2013;61:1125–36.PubMedCrossRefGoogle Scholar
  34. 34.
    Van Belle E, Rauch A, Vincent F, et al. Von Willebrand factor multimers during transcatheter aortic-valve replacement. N Engl J Med. 2016;375(4):335–44. doi: 10.1056/NEJMoa1505643.PubMedCrossRefGoogle Scholar
  35. 35.
    Willson AB, Webb JG, Labounty TM, et al. 3-dimensional aortic annular assessment by multidetector computed tomography predicts moderate or severe paravalvular regurgitation after transcatheter aortic valve replacement: a multicenter retrospective analysis. J Am Coll Cardiol. 2012;59:1287–94.PubMedCrossRefGoogle Scholar
  36. 36.
    Mylotte D, Dorfmeister M, Elhmidi Y, et al. Erroneous measurement of the aortic annular diameter using 2-dimensional echocardiography resulting in inappropriate CoreValve size selection: a retrospective comparison with multislice computed tomography. JACC Cardiovasc Interv. 2014;7:652–61.PubMedCrossRefGoogle Scholar
  37. 37.
    Jilaihawi H, Doctor N, et al. Aortic annular sizing for transcatheteraortic valve replacement using cross-sectional 3-dimensional transesophageal echocardiography. J Am Coll Cardiol. 2013;61:908–16.PubMedCrossRefGoogle Scholar
  38. 38.
    Khalique OK, Kodali SK, Paradis JM, et al. Aortic annular sizing using a novel 3-dimensional echocardiographic method use and comparison with cardiac computed tomography. Circ Cardiovasc Imaging. 2014;7:155–63.PubMedCrossRefGoogle Scholar
  39. 39.
    Sinning JM, Werner N, Nickenig G, Grube E. Challenges in transcatheter valve treatment: aortic regurgitation after transcatheter aortic valve implantation. EuroIntervention. 2013;9(Suppl):S72–6.PubMedCrossRefGoogle Scholar
  40. 40.
    Nombela-Franco L, Rodes-Cabau J, DeLarochelliere R, et al. Predictive factors, efficacy, and safety of balloon post-dilation after transcatheter aortic valve implantation with a balloon-expandable valve. JACC Cardiovasc Interv. 2012;5:499–512.Google Scholar
  41. 41.
    Makkar RR, Jilaihawi H, Chakravarty T, et al. Determinants and outcomes of acute transcatheter valve-in-valve therapy or embolization: a study of multiple valve implants in the U.S. PARTNER trial (Placement of AoRTic TraNscathetER Valve Trial Edwards SAPIEN Transcatheter Heart Valve). J Am Coll Cardiol. 2013;62:418–30.PubMedCrossRefGoogle Scholar
  42. 42.
    Saia F, Martinez C, Gafoor S, et al. Long-term outcomes of percutaneous paravalvular regurgitation closure after transcatheter aortic valve replacement: a multicenter experience. JACC Cardiovasc Interv. 2015;8:681–8.PubMedCrossRefGoogle Scholar
  43. 43.
    Herrmann HC, Thourani VH, Kodali SK, et al. One-year clinical outcomes with SAPIEN 3 transcatheter aortic valve replacement in high-risk and inoperable patients with severe aortic stenosis. Circulation. 2016;134(2):130–40. doi: 10.1161/CIRCULATIONAHA.116.022797.PubMedCrossRefGoogle Scholar
  44. 44.
    Manoharan G, Walton AS, Brecker SJ, et al. Treatment of symptomatic severe aortic stenosis with a novel resheathable supra-annular self-expanding transcatheter aortic valve system. JACC Cardiovasc Interv. 2015;8(10):1359–67.PubMedCrossRefGoogle Scholar
  45. 45.
    Meredith IT, Walters DL, Dumonteil N, et al. 1-Year outcomes with the fully repositionable and retrievable lotus transcatheter aortic replacement valve in 120 high-risk surgical patients with severe aortic stenosis: results of the REPRISE II study. JACC Cardiovasc Interv. 2016;9(4):376–84.PubMedCrossRefGoogle Scholar
  46. 46.
    Schofer J, Colombo A, Klugmann S, et al. Prospective multicenter evaluation of the direct flow medical transcatheter aortic valve. J Am Coll Cardiol. 2014;63(8):763–8.PubMedCrossRefGoogle Scholar
  47. 47.
    Manoharan G, Linke A, Möllmann H, et al. Multicentre clinical study evaluating a novel resheathable annular functioning self-expanding transcatheter aortic valve system: safety and performance results at 30 days with the Portico system. EuroIntervention. 2016;12:768–74.PubMedCrossRefGoogle Scholar
  48. 48.
    Silaschi M, Treede H, Rastan AJ, et al. The JUPITER registry: 1-year results of transapical aortic valve implantation using a second-generation transcatheter heart valve in patients with aortic stenosis. Eur J Cardiothorac Surg. 2016;50(5):874–81.PubMedCrossRefGoogle Scholar
  49. 49.
    Kempfert J, Holzhey D, Hofmann S, et al. First registry results from the newly approved ACURATE TA™ TAVI system. Eur J Cardiothorac Surg. 2015;48(1):137–41.PubMedCrossRefGoogle Scholar
  50. 50.
    Webb J, Gerosa G, Lefèvre T, et al. Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve. J Am Coll Cardiol. 2014;64:2235–43. doi: 10.1016/j. jacc.2014.09.026.PubMedCrossRefGoogle Scholar
  51. 51.
    Herrmann HC. New transcatheter aortic valve prosthesis sets a new standard. J Am Coll Cardiol. 2014;64:2244–5. doi: 10.1016/j.jacc.2014.08.042.PubMedCrossRefGoogle Scholar
  52. 52.
    Ando T, Briasoulis A, Holmes AA, Taub CC, Takagi H, Afonso L. Sapien 3 versus Sapien XT prosthetic valves in transcatheter aortic valve implantation: a meta-analysis. Int J Cardiol. 2016;220:472–8. doi: 10.1016/j.ijcard.2016.06.159.PubMedCrossRefGoogle Scholar
  53. 53.
    Lefèvre T, Colombo A, Tchétché D, et al. Prospective multicenter evaluation of the direct flow medical transcatheter aortic valve system: 12-month outcomes of the evaluation of the direct flow medical percutaneous aortic valve 18F system for the treatment of patients with severe aortic stenosis (DISCOVER) study. JACC Cardiovasc Interv. 2016;9(1):68–75.PubMedCrossRefGoogle Scholar
  54. 54.
    Sondergaard L, Worthley S, Rodes J, Maisano F. Safety and performance of the Portico valve in patients with severe aortic stenosis and excessive surgical risk: a first report of 30-day results from the PORTICO I study. Published in Abstracts EuroPCR 2016, May 2016.Google Scholar
  55. 55.
    Bax JJ, Delgado V, Bapat V, et al. Open issues in transcatheter aortic valve implantation. Part 2: procedural issues and outcomes after transcatheter aortic valve implantation. Eur Heart J. 2014;35:2639–54.PubMedCrossRefGoogle Scholar
  56. 56.
    Siontis GC, Jüni P, Pilgrim T, et al. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol. 2014;64:129–40.PubMedCrossRefGoogle Scholar
  57. 57.
    Carrabba N, Valenti R, Migliorini A, et al. Impact on left ventricular function and remodeling and on 1-year outcome in patients with left bundle branch block after transcatheter aortic valve implantation. Am J Cardiol. 2015;116:125–31.PubMedCrossRefGoogle Scholar
  58. 58.
    Schymik G, Tzamalis P, Bramlage P, et al. Clinical impact of a new left bundle branch block following TAVI implantation: 1-year results of the TAVIK cohort. Clin Res Cardiol. 2015;104:351–62.PubMedCrossRefGoogle Scholar
  59. 59.
    Urena M, Webb JG, Cheema A, et al. Impact of new-onset persistent left bundle branch block on late clinical outcomes in patients undergoing transcatheter aortic valve implantation with a balloon-expandable valve. JACC Cardiovasc Interv. 2014;7:128–36.PubMedCrossRefGoogle Scholar
  60. 60.
    Houthuizen P, van der Boon RM, Urena M, et al. Occurrence, fate and consequences of ventricular conduction abnormalities after transcatheter aortic valve implantation. EuroIntervention. 2014;9:1142–50.PubMedCrossRefGoogle Scholar
  61. 61.
    Nazif TM, Williams MR, Hahn RT, et al. Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience. Eur Heart J. 2014;35:1599–607.PubMedCrossRefGoogle Scholar
  62. 62.
    Franzoni I, Latib A, Maisano F, et al. Comparison of incidence and predictors of left bundle branch block after transcatheter aortic valve implantation using the CoreValve versus the Edwards valve. Am J Cardiol. 2013;112:554–9.PubMedCrossRefGoogle Scholar
  63. 63.
    Testa L, Latib A, De Marco F, et al. Clinical impact of persistent left bundle-branch block after transcatheter aortic valve implantation with CoreValve Revalving System. Circulation. 2013;127:1300–7.PubMedCrossRefGoogle Scholar
  64. 64.
    Van der Boon RM, Nuis RJ, Van Mieghem NM, et al. New conduction abnormalities after TAVI—frequency and causes. Nat Rev Cardiol. 2012;9:454–63.PubMedCrossRefGoogle Scholar
  65. 65.
    Petronio AS, Sinning JM, Van Mieghem N, et al. Optimal implantation depth and adherence to guidelines on permanent pacing to improve the results of transcatheter aortic valve replacement with the Medtronic CoreValve system: the CoreValve prospective, international, post-Market ADVANCE-II Study. JACC Cardiovasc Interv. 2015;8:837–46.PubMedCrossRefGoogle Scholar
  66. 66.
    Urena M, Rodés-Cabau J. Managing heart block after transcatheter aortic valve implantation: from monitoring to device selection and pacemaker indications. EuroIntervention. 2015;11(suppl W):W101–5. doi: 10.4244/EIJV11SWA30.PubMedCrossRefGoogle Scholar
  67. 67.
    Tarantini G, Mojoli M, Purita P, Napodano M, D’Onofrio A, Frigo A, Covolo E, Facchin M, Isabella G, Gerosa G, Iliceto S. Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve. EuroIntervention. 2015;11:343–50. doi: 10.4244/EIJY14M11_06.PubMedCrossRefGoogle Scholar
  68. 68.
    Toggweiler S, Stortecky S, Holy E, et al. The electrocardiogram after transcatheter aortic valve replacement determines the risk for post-procedural high-degree AV block and the need for telemetry monitoring. JACC Cardiovasc Interv. 2016;9(12):1269–76.PubMedCrossRefGoogle Scholar
  69. 69.
    Regueiro A, Abdul-Jawad Altisent O, Del Trigo M, et al. Impact of new-onset left bundle branch block and periprocedural permanent pacemaker implantation on clinical outcomes in patients undergoing transcatheter aortic valve replacement: a systematic review and meta-analysis. Circ Cardiovasc Interv. 2016;9(5):e003635.PubMedCrossRefGoogle Scholar
  70. 70.
    Genereux P, Head SJ, Van Mieghem NM, et al. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol. 2012;59:2317–26.PubMedCrossRefGoogle Scholar
  71. 71.
    Genereux P, Webb JG, Svensson LG, et al. Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. J Am Coll Cardiol. 2012;60:1043–52.PubMedCrossRefGoogle Scholar
  72. 72.
    Khatri PJ, Webb JG, Rodes-Cabau J, et al. Adverse effects associated with transcatheter aortic valve implantation: a meta-analysis of contemporary studies. Ann Internal Med. 2013;158:35–46.CrossRefGoogle Scholar
  73. 73.
    Panchal HB, Ladia V, Amin P, et al. A meta-analysis of mortality and major adverse cardiovascular and cerebrovascular events in patients undergoing transfemoral versus transapical transcatheter aortic valve implantation using edwards valve for severe aortic stenosis. Am J Cardiol. 2014;114(12):1882–90.PubMedCrossRefGoogle Scholar
  74. 74.
    Steinvil A, Leshem-Rubinow E, et al. Vascular complications after transcatheter aortic valve implantation and their association with mortality reevaluated by the valve academic research consortium definitions. Am J Cardiol. 2015;115(1):100–6.PubMedCrossRefGoogle Scholar
  75. 75.
    Genereux P, Head SJ, Wood DA, et al. Transcatheter aortic valve implantation: 10-year anniversary. Part II: clinical implications. Eur Heart J. 2012;33:2399–402.PubMedCrossRefGoogle Scholar
  76. 76.
    Hayashida K, Lefèvre T, Chevalier B, et al. Transfemoral aortic valve implantation new criteria to predict vascular complications. JACC Cardiovasc Interv. 2011;4:851–8.PubMedCrossRefGoogle Scholar
  77. 77.
    Toggweiler S, Gurvitch R, Leipsic J, et al. Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure. J Am Coll Cardiol. 2012;59:113–8.PubMedCrossRefGoogle Scholar
  78. 78.
    Van Mieghem NM, Tchetche D, Chieffo A, et al. Incidence, predictors, and implications of access site complications with transfemoral transcatheter aortic valve implantation. Am J Cardiol. 2012;110:1361–7.PubMedCrossRefGoogle Scholar
  79. 79.
    Barbash IM, Barbanti M, Webb J, et al. Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation. Eur Heart J. 2015;36(47):3370–9.PubMedCrossRefGoogle Scholar
  80. 80.
    Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609–20.PubMedCrossRefGoogle Scholar
  81. 81.
    Holmes DR, Brennan JM, Rumsfeld JS, et al. Clinical outcomes at 1 year following transcatheter aortic valve replacement. JAMA. 2015;313:1019–28.PubMedCrossRefGoogle Scholar
  82. 82.
    Walther T, Hamm CW, Schuler G, et al. Perioperative results and complications in 15,964 transcatheter aortic valve replacements: prospective data from the GARY registry. J Am Coll Cardiol. 2015;65:2173–80.PubMedCrossRefGoogle Scholar
  83. 83.
    Eggebrecht H, Schmermund A, Voigtlander T, Kahlert P, Erbel R, Mehta RH. Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention. 2012;8:129–38.PubMedCrossRefGoogle Scholar
  84. 84.
    Auffret V, Regueiro A, Del Trigo M, et al. Predictors of early cerebrovascular events in patients with aortic stenosis undergoing transcatheter aortic valve replacement. J Am Coll Cardiol. 2016;68(7):673–84.PubMedCrossRefGoogle Scholar
  85. 85.
    Bendszus M, Stoll G. Silent cerebral ischaemia: hidden fingerprints of invasive medical procedures. Lancet Neurol. 2006;5:364–72.PubMedCrossRefGoogle Scholar
  86. 86.
    Fairbairn TA, Mather AN, Bijsterveld P, Worthy G, Currie S, Goddard AJ, Blackman DJ, Plein S, Greenwood JP. Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status. Heart. 2012;98:18–23.PubMedCrossRefGoogle Scholar
  87. 87.
    Rodes-Cabau J, Dumont E, Boone RH, Larose E, Bagur R, Gurvitch R, Bedard F, Doyle D, De Larochelliere R, Jayasuria C, Villeneuve J, Marrero A, Cote M, Pibarot P, Webb JG. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol. 2011;57:18–28.PubMedCrossRefGoogle Scholar
  88. 88.
    Drews T, Pasic M, Buz S, et al. Transcranial Doppler sound detection of cerebral microembolism during transapical aortic valve implantation. Thorac Cardiovasc Surg. 2011;59:237–42.PubMedCrossRefGoogle Scholar
  89. 89.
    Miller DC, Blackstone EH, Mack MJ, et al. Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial. J Thorac Cardiovasc Surg. 2012;143:832–843.e13.PubMedCrossRefGoogle Scholar
  90. 90.
    Athappan G, Gajulapalli RD, Sengodan P, et al. Influence of transcatheter aortic valve replacement strategy and valve design on stroke after transcatheter aortic valve replacement: a meta-analysis and systematic review of literature. J Am Coll Cardiol. 2014;63:2101–10.PubMedCrossRefGoogle Scholar
  91. 91.
    Nombela-Franco L, Webb JG, de Jaegere PP, et al. Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation. Circulation. 2012;126:3041–53.PubMedCrossRefGoogle Scholar
  92. 92.
    Freeman M, Barbanti M, Wood DA, et al. Cerebral events and protection during transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2014;84:885–96.PubMedCrossRefGoogle Scholar
  93. 93.
    Rodes-Cabau J, Kahlert P, Neumann F-J, et al. Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study. JACC Cardiovasc Interv. 2014;7:1146–55.PubMedCrossRefGoogle Scholar
  94. 94.
    Lansky AJ, Schofer J, Tchetche D, et al. A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial. Eur Heart J. 2015;36:2070–8.PubMedCrossRefGoogle Scholar
  95. 95.
    Van Mieghem NM, Schipper MEI, Ladich E, et al. Histopathology of embolic debris captured during transcatheter aortic valve replacement. Circulation. 2013;127:2194–201.PubMedCrossRefGoogle Scholar
  96. 96.
    Ribeiro HB, Webb JG, Makkar RR, et al. Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry. J Am Coll Cardiol. 2013;62:1552–62.PubMedCrossRefGoogle Scholar
  97. 97.
    Généreux P, Head SJ, Van Mieghem NM, Kodali S, Kirtane AJ, Xu K, Smith C, Serruys PW, Kappetein AP, Leon MB. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol. 2012;59:2317–26.PubMedCrossRefGoogle Scholar
  98. 98.
    Barbanti M, Yang T-H, Rodes-Cabau J, et al. Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement. Circulation. 2013;128:244–53.PubMedCrossRefGoogle Scholar
  99. 99.
    Pasic M, Unbehaun A, Dreysse S, Buz S, Drews T, Kukucka M, D’Ancona G, Seifert B, Hetzer R. Rupture of the device landing zone during transcatheter aortic valve implantation: a life-threatening but treatable complication. Circ Cardiovasc Interv. 2012;5:424–32.PubMedCrossRefGoogle Scholar
  100. 100.
    Rezq A, Basavarajaiah S, Latib A, et al. Incidence, management, and outcomes of cardiac tamponade during transcatheter aortic valve implantation: a single-center study. JACC Cardiovasc Intervent. 2012;5:1264–72.CrossRefGoogle Scholar
  101. 101.
    Córdoba-Soriano JG, Puri R, Amat-Santos I, et al. Valve thrombosis following transcatheter aortic valve implantation: a systematic review. Rev Esp Cardiol (Engl Ed). 2015;68(3):198–204.CrossRefGoogle Scholar
  102. 102.
    Latib A, Naganuma T, Abdel-Wahab M, et al. Treatment and clinical outcomes of transcatheter heart valve thrombosis. Circ Cardiovasc Interv. 2015;8.Google Scholar
  103. 103.
    Del Trigo M, Muñoz-Garcia AJ, Wijeysundera HC, et al. Incidence, timing, and predictors of valve hemodynamic deterioration after transcatheter aortic valve replacement: multicenter registry. J Am Coll Cardiol. 2016;67:644–55.PubMedCrossRefGoogle Scholar
  104. 104.
    Leetmaa T, Hansson NC, Leipsic J, et al. Early aortic transcatheter heart valve thrombosis: diagnostic value of contrast-enhanced multidetector computed tomography. Circ Cardiovasc Interv. 2015;8.Google Scholar
  105. 105.
    Pache G, Schoechlin S, Blanke P, et al. Early hypo-attenuated leaflet thickening in balloon-expandable transcatheter aortic heart valves. Eur Heart J. 2016;37(28):2263–71.PubMedCrossRefGoogle Scholar
  106. 106.
    Hansson NC, Grove EL, Andersen HR, et al. Transcatheter aortic heart valve thrombosis: incidence, predisposing factors, and clinical implications. J Am Coll Cardiol. 2016;68(19):2059–69. pii: S0735-1097(16)34936-1PubMedCrossRefGoogle Scholar
  107. 107.
    Holmes DR Jr, Mack MJ, Kaul S, et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collabration with the American Heart Association, American Society of Echocardiography, European Association for CardioThoracic Surgery, Heart Failure Society of America, Mended Hearts, Society of Cardiovascular Anesthesiologists, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J Thorac Cardiovasc Surg. 2012;144:e29–84.PubMedCrossRefGoogle Scholar
  108. 108.
    Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2012;42:S1–S44.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Quebec Heart and Lung Institute, Laval UniversityQuebec CityCanada

Personalised recommendations